2Sarkar R, Meinberg EG, Stanley JC, et al. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res, 1996,78:225
3Robinson LJ, Michel T. Mutagenesis of palmitoylation site in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subeellar targeting[J]. Proc Natl Acad Sci USA, 1995,92(25) :11776
4Feldman LJ,Tahil O, Steg G. Perpectives of arterial gene therapy for the prevention of restenosis[J]. Circ Res, 1996,32 : 194
5Mundt S, Chun S, Fletcher D, et al. Deficiency in inducible apolipoprotion E-deficient mice[J].J Immcenol,2000,165(6) :3430
6Aroon D,Hingorani, Chia Fan liang, et al. A common variant of endothelial nitric oxide synthase(Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation, 1999,100:1515
7Kiyoshi Hibi, Tomoaki I, kouichi T, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension, 1998,32:521
8Cai H, Wilcken DE, Wang XL. The Glu298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med, 1999,77:511
9Wang XL,Sim AS, et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med, 1996,2:41
10Esaki T, Hayashi T, Muto E, et al. Expression of inducible nitric oxide syntbase in T lymphocytes and macrophagea of cholesterolfed rabbites [J]. Atherosclerosis, 1997,128 ( 1 ) :39
